Makindo Medical Notes

Related Subjects: |Fever in a traveller |Malaria Falciparum |Malaria Non Falciparum |Viral Haemorrhagic Fevers (VHF) |Lassa fever |Dengue |Marburg virus disease |AIDS HIV |Yellow fever |Ebola Virus |Leptospirosis | Crimean-Congo haemorrhagic fever |African Trypanosomiasis (Sleeping sickness) |American Trypanosomiasis (Chagas Disease) |Incubation Periods |Notifiable Diseases UK

About Rickettsia conorii

• Organism: Rickettsia conorii is a Gram-negative, obligate intracellular bacterium.
• Disease: It is the causative agent of Mediterranean Spotted Fever, also known as Boutonneuse fever-type tick bite fever.

Characteristics

• Size and Staining: Although Gram-negative, R. conorii is extremely small and may not be easily visualized on routine Gram staining.
• Intracellular Lifestyle: As an obligate intracellular parasite, it relies on host cell ATP for energy and can only grow in tissue culture or within living cells.

Source and Geographic Distribution

• Endemic Region: The infection is commonly reported from South Africa and other Mediterranean and African regions where the vector is prevalent.
• Transmission: It is transmitted by tick bites, which introduce the bacteria into the bloodstream during feeding.

Clinical Features

• Incubation Period: Symptoms typically appear within 5–7 days after the tick bite, and the condition is more common during summer months and in higher temperatures.
• Symptomatology: Patients often present with severe headache, fever, and malaise. A maculopapular rash may develop after about 3 days and can involve the palms and soles.
• Eschar Formation: An eschar—a central necrotic lesion surrounded by inflamed skin—is frequently seen at the site of the infected tick bite, often in hidden areas such as beneath scalp hair, behind the ear, or in the anogenital region.
• Severity: The illness can range from moderate to severe, with a risk of severe or even fatal complications in some cases.

Complications

• Neurological involvement, including encephalitis, confusion, or coma
• Pulmonary complications such as pneumonia and pulmonary embolism (secondary to deep vein thrombosis)
• Other severe outcomes may include bleeding, gangrene, hepatorenal failure, and myocarditis

Differential Diagnosis

• Meningococcal septicaemia
• Other Gram-negative septicaemias
• Viral haemorrhagic fevers, such as Crimean-Congo haemorrhagic fever

Investigations

• Laboratory Findings: Blood tests often reveal raised neutrophils and thrombocytopenia (low platelet count).
• Liver Function: Elevated AST and ALT levels may be observed, reflecting hepatic involvement.
• Serologic and Molecular Testing: Confirmation is achieved using serological assays or PCR to detect Rickettsia DNA.

Management

• First-Line Therapy: Doxycycline is the treatment of choice for Mediterranean Spotted Fever.
• Alternative Agents: In cases where doxycycline is contraindicated, ciprofloxacin or chloramphenicol may be considered.
• Supportive Care: Management also includes supportive treatments to address fever, pain, and any complications.

Conclusion

Rickettsia conorii is an intracellular Gram-negative bacterium responsible for Mediterranean Spotted Fever. Clinically, the infection presents with an incubation period of 5–7 days, severe headache, fever, and a characteristic rash involving the palms and soles, along with a typical eschar at the tick bite site. Laboratory investigations reveal elevated neutrophils, low platelets, and increased liver enzymes. Prompt treatment with doxycycline is essential, while alternative antibiotics may be used if necessary. Awareness of its clinical presentation and potential complications is crucial for timely diagnosis and management, particularly in endemic areas.